Sjögren's syndrome.

Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol (2014) 1.20

Prosthodontic Rehabilitation in Sjogren's Syndrome with a Simplified Palatal Reservoir: Two Year Follow Up. J Indian Prosthodont Soc (2011) 0.81

Identification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarrays. Rheumatol Int (2014) 0.80

Factors regulating immunoglobulin production by normal and disease-associated plasma cells. Biomolecules (2015) 0.78

Improvement in lacrimal and salivary secretions after alkali therapy in Sjøgren's syndrome with renal tubular acidosis. Ann Rheum Dis (1976) 0.75

Sjogren's syndrome. Br Med J (1973) 0.75

SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46

Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol (1968) 6.61

Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22

THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07

Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76

A clinicopathologic study of Mikulicz's disease. Am J Pathol (1953) 3.17

Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med (1967) 2.92

Observations on the pathology of Sjögren's syndrome. J Pathol Bacteriol (1954) 2.51

Mitochondrial antibodies and subclinical liver disease. Q J Med (1970) 2.28

"Sicca complex" in liver disease. Br Med J (1970) 2.22

Post-mortem prevalence of focal lymphocytic adenitis of the submandibular salivary gland. J Pathol Bacteriol (1966) 2.04

The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement. Ann Intern Med (1969) 1.79

Gastric studies in sjögren's syndrome. Gut (1966) 1.73

Sjögren's syndrome and thyroid disease. Br J Ophthalmol (1967) 1.64

Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin Exp Immunol (1968) 1.60

Antinucleolar antibodies. Lancet (1962) 1.52

Interstitial nephritis in Sjögren's syndrome. Ann Intern Med (1968) 1.44

SJOEGREN'S SYNDROME AND ITS RELATION TO CONNECTIVE TISSUE DISEASES. J Chronic Dis (1963) 1.33

NEPHROGENIC DIABETIC INSIPIDUS AND OTHER DEFECTS OF RENAL TUBULAR FUNCTION IN SJOERGREN'S SYNDROME. Am J Med (1965) 1.29

Sjögren's syndrome associated with lymphoblastoma and hypersplenism. AMA Arch Derm Syphilol (1951) 1.18

Benign hypergammaglobulinemic purpura of Waldenström. Medicine (Baltimore) (1971) 1.04

The systemic manifestations of Sjögren's syndrome: report of glandular function with histologic, bacterial and viral studies. Ann Intern Med (1958) 1.02

Malignant histopathologic counterpart of the benign lymphoepithelial lesion. Cancer (1970) 0.97

Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97

Diagnostic value of quantitative scintiscanning of the salivary glands in Sjögren's syndrome and rheumatoid arthritis. Clin Sci (1971) 0.87

THE RELATION OF SJOEGREN'S SYNDROME TO RHEUMATOID ARTHRITIS. Acta Rheumatol Scand (1964) 0.83

Penicillin allergy in rheumatoid arthritis. With special reference to Sjogren's syndrome. Ann Rheum Dis (1969) 0.82

Sjögren's syndrome in relation to pernicious anaemia and idiopathic Addison's disease. Br J Ophthalmol (1970) 0.78

The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67

Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med (1976) 7.00

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71

Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40

Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04

Systemic lupus erythematosus. Lancet (2001) 4.18

Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76

Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53

Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med (1980) 3.50

Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43

Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39

The anticardiolipin syndrome. J Rheumatol (1986) 3.36

The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02

Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86

Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science (1976) 2.70

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63

Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51

Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23

Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12

Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10

Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09

Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07

Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01

Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00

Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92

Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85

Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83

A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80

Recurrent deep vein thrombosis and Addison's disease in "primary" antiphospholipid syndrome. J Rheumatol (1989) 1.77

Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77

Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76

Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.76

Central nervous system lupus--diagnosis and treatment. J Rheumatol (1980) 1.75

Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet (1978) 1.75

Neuropsychiatric problems in systemic lupus erythematosus. Br Med J (1972) 1.74

Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis (1989) 1.73

Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69

Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68

Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol (1984) 1.67

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66

Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66

Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis (1982) 1.64

Deficiency of factor B of the complement system in sickle cell anaemia. Br Med J (1976) 1.61

Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61

Hypoadrenalism, Addison's disease and antiphospholipid antibodies. J Rheumatol (1991) 1.60

Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol (1985) 1.60

The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60

Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59

Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum (1979) 1.57

Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol (1977) 1.57

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol (1985) 1.56

Significance of persisting serologic abnormalities in SLE. Arthritis Rheum (1976) 1.56

Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol (1971) 1.56

The release of DNA into serum and synovial fluid. Arthritis Rheum (1971) 1.56

Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis (1983) 1.55

Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol (1997) 1.55

An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1979) 1.54

Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med (1984) 1.54

Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol (1998) 1.54

Endomyocardial complications of the Churg-Strauss syndrome. Postgrad Med J (1985) 1.54

Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis (1982) 1.53

The anticardiolipin syndrome. Clin Exp Rheumatol (1986) 1.53

Rheumatoid arthritis and food: a case study. Br Med J (Clin Res Ed) (1981) 1.52

Ear, nose, and throat symptoms in subacute Wegener's granulomatosis. BMJ (1989) 1.52

Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med (1984) 1.52

Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52

Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost (1997) 1.52

A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol (1991) 1.51

Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50

Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed) (1982) 1.50

The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol (1984) 1.48

Systemic lupus erythematosus in childhood. Ann Rheum Dis (1981) 1.48

Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45

Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease. Arthritis Rheum (1982) 1.45

Clinical and immunologic features of livedo reticularis in lupus: a case-control study. Am J Med (1989) 1.44

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol (1996) 1.44

Current transport of leatherback sea turtles (Dermochelys coriacea) in the ocean. Proc Biol Sci (2003) 1.44

Systemic lupus erythematosus: two patients treated with danazol. Br Med J (Clin Res Ed) (1982) 1.43

Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS) Br J Rheumatol (1993) 1.42

Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost (2001) 1.41

Systemic lupus erythematosus: treatment and prognosis. Br Med J (1979) 1.41

Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41

Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system. Lupus (1997) 1.40

Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Ann Rheum Dis (1969) 1.39

Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. J Rheumatol (1993) 1.39

Cutaneous photosensitivity in dermatomyositis. Br J Dermatol (1994) 1.38

Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Clin Exp Immunol (1983) 1.38

Antiphospholipid antibodies--autoantibodies with a difference. Annu Rev Med (1988) 1.38

Antiphospholipid antibodies cross-reacting with erythrocyte membranes. A case report. Clin Exp Rheumatol (1992) 1.38

C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. J Clin Invest (1976) 1.38